Chudasama Rajesh K, Kadri A M, Ratnu Apurva, Jain Mahima, Kamariya Chandrakant P
Department of Community Medicine, PDU Government Medical College, Rajkot, Gujarat, India.
Maternal Health Division, UNICEF, New Delhi, India.
Indian J Community Med. 2019 Apr-Jun;44(2):142-146. doi: 10.4103/ijcm.IJCM_283_18.
Gestational diabetes mellitus (GDM) occurs during pregnancy which affects mother, fetus, and outcome of pregnancy, hence early detection is necessary. The objective of this study was to ascertain the validity of glucometer over standard biochemical testing for detection of GDM and to estimate prevalence of GDM and its associated risk factors.
A hospital-based study was conducted at Antenatal clinics of Obstetrics Department, tertiary care hospital, based on the "National Guidelines for Diagnosis and Management of GDM." Totally 357 pregnant women between 21 and 28 weeks of gestational age agreed were included in the study from January to March 2016. After obtaining written consent, one step procedure was offered to pregnant women by giving 75 g of anhydrous glucose dissolving in 200-250 ml of water. After 2 h, glucose level was estimated by capillary testing with glucometer and venous glucose by glucose oxidase test.
GDM was found in 20.4% pregnant women with capillary testing done by glucometer compare to 11.5% with venous blood testing. GDM was found higher among literates, homemakers, Hindus, people living in nuclear family, belongs to middle class, residing in urban area, primigravidae, obese and with gestational age between 21 and 24 weeks. Intermediate agreement (Kappa = 0.42) was found between two methods with sensitivity of 70.7%, specificity of 86.1%, positive predictive value 39.7%, and negative predictive value 95.8%.
Intermediate agreement between two methods indicates glucometer testing can be used to screen pregnant women at an early gestational age (21 weeks), at the community level by health-care workers.
妊娠期糖尿病(GDM)发生于孕期,会影响母亲、胎儿及妊娠结局,因此早期检测很有必要。本研究的目的是确定血糖仪检测相对于标准生化检测在GDM检测中的有效性,并评估GDM的患病率及其相关危险因素。
基于“GDM诊断与管理国家指南”,在一家三级护理医院的产科门诊进行了一项基于医院的研究。2016年1月至3月,共有357名孕龄在21至28周的孕妇同意参与研究。获得书面同意后,为孕妇提供一步法,即给予75克无水葡萄糖溶于200 - 250毫升水中。2小时后,用血糖仪进行毛细血管检测估计血糖水平,并用葡萄糖氧化酶法检测静脉血糖。
通过血糖仪进行毛细血管检测发现20.4%的孕妇患有GDM,而静脉血检测发现11.5%的孕妇患有GDM。在识字者、家庭主妇、印度教徒、核心家庭居住者、中产阶级、城市居住者、初产妇、肥胖者以及孕龄在21至24周的孕妇中,GDM的患病率更高。两种方法之间存在中度一致性(Kappa = 0.42),敏感性为70.7%,特异性为86.1%,阳性预测值为39.7%,阴性预测值为95.8%。
两种方法之间的中度一致性表明,血糖仪检测可由医护人员在社区层面用于筛查孕早期(21周)的孕妇。